NHSBSA - Freedom of Information

You are at: NHSBSA Home Page | Freedom of Information

Previous Request List - Detail

Request Reference: 7788 Request Date: 26 Jun 2018
Request: Dear Sirs, Please would you kindly provide annual prescription data for the following antidepressants from 2008 to 2017 for England, Wales, Scotland and N. Ireland. 1. Seroxat GSK UK Ltd & all generics of paroxetine; 2. Prozac Eli Lilly and Company Ltd. & all generics of fluoxetine; 3. Cipramil Lunbeck Ltd & all generics of citalopram; 4. Cipralex Lundbeck Ltd & all generics of escitalopram;5. Faverin Mylan Products Ltd & all generics of fluvoxamine; 6. Lustral Pfizer Ltd & all generics of sertraline; and 7. Venlafaxine and all generics (venladex, Vencarm XL, Venaxx XL). The data should separate Cipramil,Cipralex, Lustral, Faverin, Prozac, Seroxat and Venlafaxine from their generics. [On 23 July 2018 you clarified the following:] • Do you require the data for calendar year totals at presentation level for the products listed in your request? Yes please. When you say “at presentation” do you mean those prescriptions presented to pharmacies for collection rather than the no. of prescriptions issued by prescribers? • What prescription data do you require? Eg. Number of prescription items, Net Ingredient Cost. Number of prescriptions and cost please. I do not require a breakdown of mg tablets. However, for Seroxat and Prozac there is an oral formulation and for Cipramil (citalopram); Cipralex (excitalopram) there are oral drops. I request the number of prescriptions issued for these per year for the 5 years of your records. Please note the following: • We hold prescription data for 5 years so we would only be able to provide data for this time period. Agreed • We hold data for items prescribed in England and dispensed in England and Wales and for items prescribed in the UK and dispensed in England. Prescriptions issued in England and dispensed in England and Wales [On 23 July 2018 you raised the further questions:] From the data you hold are you able to distinguish repeat prescriptions from new prescriptions? If so, I would like to know how many prescriptions per annum comprise new prescriptions for each SSRI and its generic versions (data to be presented separately for each). Also, are you able to distinguish between prescriptions issued in primary care as opposed to secondary care? If so, I request this data. Please could you provide contact details of your counterparts in N. Ireland, Wales and Scotland to whom this request may be sent.

Status: Complete
Response Date: 20 Aug 2018
Response: Please see attached response

References: